Eastland Medical Systems (ASX EMS) is looking to significantly increase revenues in 2008 as a result of its decision to concentrate on the development of its Pharmaceutical Division - with fast-track low-risk pharmaceutical development and early market entry of pharmaceutical product.
HELICON GROUP LIMITED (ASX: HCG) signed a cooperation agreement with Jewim Pharmaceuticals Inc, a leading player in the Chinese pharmaceutical industry.
The Directors of Solagran Limited are pleased to advise that the Annual General
Meeting of Solagran Limited has been re-scheduled for 11.00am on Friday 21
December, 2007 at the Boulevard Room, St Kilda Road Parkview Hotel, 562 St Kilda
Road, Melbourne.
Bioeffectives to be Used to Treat Alzheimer's Patients and Alcoholics in Russia The Directors of Solagran Limited are pleased to release a letter received from Dr Nina Golovkina, the Head of the Department of Psychosomatics at the Skvortsova- Stepanova Psychiatric Hospital in St Petersburg, confirming the very positive results of trials conducted by that hospital
HELICON GROUP LIMITED (ASX code: HCG) announced the release of its 2007 Annual Report, the first as a publicly listed company.
Signing of an exclusive agreement with one of the world's largest pharmaceutical groups in December 2006 to develop the UnitractTM Prefilled Syringe for one of its major drug products. After a successful review of product specifications in July 2007, both parties are now finalizing an extension of this agreement.
HELICON GROUP LIMITED (ASX: HCG) announced today that the Chinese regulatory authority, the State Food and Drug Administration (SFDA) has formally accepted Helicon's dossier seeking marketing approval for the China market for ReCell(R).
